SCHEMBL7077598

SCHEMBL7077598

CC(C)(C)c1ccc(-c2cc(O)cc(O)c2)cc1O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.48
ALOX15 P16050 4/20 0.48
SMN1; SMN2 Q16637 4/20 0.48
CYP1A2 P05177 2/20 0.48
KDM4E B2RXH2 1/20 0.48
MAPT P10636 1/20 0.48
ATP2A2 P16615 1/20 0.48
ATP2A3 Q93084 1/20 0.48
ABL1 P00519 3/20 0.46
ABCB1 P08183 3/20 0.46
BCR P11274 3/20 0.46
CYP2C9 P11712 2/20 0.45
TYR P14679 2/20 0.45
LMNA P02545 2/20 0.45
NR1I2 O75469 1/20 0.45
MIF P14174 1/20 0.45
HTT P42858 1/20 0.45
NFE2L2 Q16236 1/20 0.45
HSD17B10 Q99714 1/20 0.45
CA2 P00918 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21035191 0.89 ALDH1A1 (0.59) ALDH1A1ALOX15SMN1; SMN2CYP1A2KDM4E
SCHEMBL7081808 0.84 ALDH1A1 (0.61) ALDH1A1ALOX15SMN1; SMN2CYP1A2KDM4E
SCHEMBL5193876 0.80 ALDH1A1 (0.48) ALDH1A1ALOX15SMN1; SMN2CYP1A2KDM4E
SCHEMBL6878804 0.80 ALOX5 (0.57) ALDH1A1ALOX15SMN1; SMN2CYP1A2KDM4E
SCHEMBL71137 0.76 ALDH1A1 (0.67) ALDH1A1ALOX15SMN1; SMN2CYP1A2KDM4E
SCHEMBL30504082 0.76 ALDH1A1 (0.67) ALDH1A1ALOX15SMN1; SMN2CYP1A2KDM4E
SCHEMBL6881273 0.76 ALDH1A1 (0.43) ALDH1A1ALOX15SMN1; SMN2CYP1A2KDM4E
SCHEMBL12732749 0.74 HSP90AA1 (0.52) ALDH1A1ALOX15SMN1; SMN2CYP1A2KDM4E
Methane SCHEMBL29280342 0.74 ALDH1A1 (0.64) ALDH1A1ALOX15SMN1; SMN2CYP1A2KDM4E
Methane SCHEMBL29280341 0.74 ALDH1A1 (0.64) ALDH1A1ALOX15SMN1; SMN2CYP1A2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030139479-A1 Non-halogenated biphenyl triol compounds, antimicrobial compositions containing the same, and methods of using the same WARNER-LAMBERT COMPANY 2003-07-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030139479-A1 Non-halogenated biphenyl triol compounds, antimicrobial compositions containing the same, and methods of using the same AS3MT, PTPN1, NONO ALDH1A1 3382/4885ALOX15 1585/4885SMN1; SMN2 4306/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.